title: Postexposure rabies prophylaxis in a patient with lymphoma.
authors.forename: E
authors.initials: E
authors.lastname: Hay
authors.forename: H
authors.initials: H
authors.lastname: Derazon
authors.forename: N
authors.initials: N
authors.lastname: Bukish
authors.forename: S
authors.initials: S
authors.lastname: Scharf
authors.forename: S
authors.initials: S
authors.lastname: Rishpon
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000032:analysis*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001733:Bites and Stings; D002335:Carnivora / Q000821:virology; D004334:Drug Administration Schedule; D006801:Humans; D016867:Immunocompromised Host; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000627:therapeutic use; D008223:Lymphoma / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D011818:Rabies / Q000150:complications / Q000276:immunology* / Q000517:prevention & control* / Q000635:transmission; D011819:Rabies Vaccines / Q000008:administration & dosage* / Q000627:therapeutic use; D011820:Rabies virus / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007136:Immunoglobulins; D011819:Rabies Vaccines